Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
Aly, T.A., Ide, A., Jahromi, M.M., Barker, J.M., Fernando, M.S., Babu, S.R., Yu, L.P., Miao, D., Erlich, H.A., Fain, P.R., et al. (2006). Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A 103, 14074-14079.
Amor, S., Puentes, F., Baker, D., and van der Valk, P. (2010). Inflammation in neurodegenerative diseases. Immunology 129, 154-169.
Anderson, S., Jung, F.F., and Ingelfinger, J.R. (1993). Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265, F477-486.
Arroyo, D.S., Soria, J.A., Gaviglio, E.A., Rodriguez-Galan, M.C., and Iribarren, P. (2011). Toll-like receptors are key players in neurodegeneration. International immunopharmacology 11, 1415-1421.
Babcock, A.A., Wirenfeldt, M., Holm, T., Nielsen, H.H., Dissing-Olesen, L., Toft-Hansen, H., Millward, J.M., Landmann, R., Rivest, S., Finsen, B., et al. (2006). Toll-like receptor 2 signaling in response to brain injury: An innate bridge to neuroinflammation. J Neurosci 26, 12826-12837.